Clinical trial
Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in…
NCT00499863 · Noven Therapeutics, Industry · Completed
Key facts
| NCT number | NCT00499863 |
|---|---|
| Title | Evaluate the Efficacy &Safety of Methylphenidate Transdermal System (MTS) in Adolescents Aged 13-17 Years With ADHD |
| Official title | A Phase IIIb, Randomized, Double-Blind, Multi-Center, Parallel-Group, Placebo-Controlled, Dose Optimization Study, Designed to Evaluate the Efficacy and Safety of MTS in Adolescents Aged 13-17 Years With ADHD |
| Lead sponsor | Noven Therapeutics, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | ADHD |
| Intervention type | Drug |
| Interventions | methylphenidate transdermal system, Placebo |
| Enrollment | 217 |
| Start date | Jul 1, 2007 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Jul 12, 2007 |
| Last update posted | Apr 26, 2017 |
| Countries | United States |
At a glance
- 10–99 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: